Zofran lawsuits claim the manufacturer failed to warn patients of the possibility of birth defects associated with the anti-nausea drug
In 2012, GlaxoSmithKline agreed to plead guilty to charges filed by the U
Many patients have filed claims in the Zofran lawsuit after giving birth to babies who suffer from heart defects and other complications
Two additional Zofran lawsuits, with plaintiffs from Mississippi and Texas, have been transferred to Zofran MDL 2675 pending in U
The Four Seasons’ smart establishment, which ranked in Latin America’s 50 Best
A lot of people
A federal appeals court on Monday declined to revive hundreds of lawsuits by women who claim that GlaxoSmithKline Plc failed to warn them that taking the anti-nausea drug Zofran during pregnancy could cause birth defects
The controversy stems from the off-label promotion of Zofran for pregnancy-related nausea, despite lacking FDA approval for this specific use
Families affected by Zofran side effects still have time to add their claims to the pending Zofran litigation at this time
Zofran Litigation
The Purpose of Prescribed Zofran
In October 2015, federal judges centralized Zofran lawsuits into a Multi-District Litigation (MDL No
This Document Relates To: ) ) All Actions ) _____) MEMORANDUM AND ORDER ON DEFENDANT’S RENEWED MOTION FOR SUMMARY JUDGMENT BASED ON FEDERAL PREEMPTION SAYLOR, C
Personal Injury Attorneys
Email; Emily Miller is an award-winning journalist with 7 years of professional experience writing and editing content for reputable media organizations across the U
The drug In February 2015, a Massachusetts mother filed a lawsuit after she was prescribed Zofran and her baby was born with several congenital defects
Plaintiffs allege, among other things, On 10/13/2015 In Re Zofran Ondansetron Products Liability Litigation was filed as a Personal Injury - Medical/Pharmaceutical Product Liability lawsuit
Dennis Saylor, IV
Oral dosage forms were approved in 1995 for the treatment of post-operative nausea and vomiting and an oral disintegrating tablet, Zofran ODT, was approved in
By 2018, over 600 lawsuits had been filed, a number of which were selected for “bellwether” test trials
Filing a lawsuit is the best means for individual consumers to hold pharmaceutical companies accountable for harmful products
2023) In this appeal arising out of a multidistrict litigation concerning the pharmaceutical drug ondansetron hydrochloride, better known as Zofran, the First Circuit affirmed the order of the district court granting summary judgment in favor of GlaxoSmithKline (GSK The Zofran birth defect lawsuit claims that GSK fraudulently represented to pregnant women and the medical community that the medication had been tested; that using Zofran while pregnant did not increase the likelihood of birth defects; and that the drug was considered a “pregnancy category B” which means animal studies showed no signs of